Royal Brompton & Harefield NHS Foundation Trust chooses CSC for transformational IT systems

Trust to deploy Lorenzo electronic patient record system, and the MedChart electronic medication management system

CSC has today announced that Royal Brompton & Harefield NHS Foundation Trust has chosen two of its healthcare software solutions.

The trust, the largest specialist heart and lung centre in the UK, will employ the Lorenzo electronic patient record (EPR) system, and the MedChart electronic medication management system.

Joanna Smith, chief information officer at the trust, said: “We set out to choose the technology for our transformation programme on a ‘best-of-breed’ basis. Through a rigorous competitive process, we concluded that CSC’s Lorenzo and MedChart will allow us to accelerate our transformation plan, and enable us to provide better care for patients.”

Lorenzo is a fully-featured next-generation EPR, which has been designed specifically to meet the needs of NHS hospital trusts. It is already live in 12 NHS trusts, with a further five deploying over the next year. Royal Brompton & Harefield NHS Foundation Trust is the second to take Lorenzo outside of the terms of a central agreement between CSC and the UK Department of Health.

MedChart, is already used by leading hospitals in Australia, New Zealand and the UK. It is a web-based solution, which includes electronic prescribing, pharmacy review, drug administration and clinical decision support. Designed by clinicians, it streamlines the medication prescribing, pharmacy review and administration processes to reduce risk, harm, confusion, error and inefficiency and improve coordination between clinical teams.

Philippe Houssiau, CSC vice president responsible for UK Healthcare, said: “We are delighted that Royal Brompton & Harefield NHS Foundation Trust has chosen both Medchart and Lorenzo. Lorenzo will bring real clinical benefits, including easier access and sharing of information, improved clinical risk management and quicker referral triage. Independent studies have shown that MedChart is associated in a significant reduction in medical errors. We look forward to building on our existing relationship with the Trust as it continues to transform care delivery.”

Companies